POXEL Poxel S.A.

0.1503USD0.1370 EUR · EPA-4.86%Mkt Cap: 10.06M USDP/E: —

Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic pathophysiology, type 2 diabetes, and liver diseases. It also develops treatments for rare metabolic diseases and associated…

Institutional holders1 on file

Key Statistics

Company
Market Cap10.06M USD
Enterprise Value73.83M USD
Revenue (TTM)8.40M USD
Gross Profit4.37M USD
Net Income (TTM)-14.99M USD
Revenue/Share0.16 USD
Last Price0.1503 USD
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees5
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0012432516
Valuation
P/E (Trailing)—
P/E (Forward)0.15
PEG—
EV/EBITDA—
EV/Revenue8.79
P/S1.20
P/B-0.12
EPS (TTM)-0.29 USD
EPS (Forward)1.01 USD
52W Range
0.14282% of range0.5265
52W High0.5265 USD
52W Low0.1428 USD
Profitability
Gross Margin52.02%
Oper. Margin-22.92%
EBITDA Margin0.00%
Profit Margin-178.45%
ROE—
ROA-20.72%
ROIC—
ROCE—
Growth
Revenue Growth87.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.33M USD
CapEx (TTM)—
FCF Margin-133.37%
FCF Yield-111.32%
Net Debt65.76M USD
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity-0.96
Current Ratio0.26
Quick Ratio0.23
Book Value/Sh-1.25 USD
Cash/Share0.04 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.66.96M
Float—
Insiders5.73%
Institutions0.00%
Technical
SMA 500.1788 (-16.0%)
SMA 2000.2362 (-36.4%)
Beta1.31
S&P 52W Chg12.00%
Avg Vol (30d)954.17K
Avg Vol (10d)343.91K
Technical Indicators
RSI (14)38.3
MACD-0.0066
MACD Signal-0.0050
MACD Hist.-0.0016
BB Upper0.1913 USD
BB Middle0.1707 USD
BB Lower0.1501 USD
BB Width24.12%
ATR (14)0.0120 USD
Vol Ratio (20d)1.22x

About Poxel (EPA: POXEL)

›

Poxel (EPA: POXEL) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 5 employees.

The shares were at 0.1370 EUR on 19 November 2026, down 40.4% over 52 weeks. Its 52-week range is 0.1302 EUR to 0.4800 EUR: the price is 71.5% below the high and 5.2% above the low.

Its market capitalisation is 9.17M EUR.

Poxel reports an operating margin of -22.9% and revenue up 87.9% year over year.

Its debt exceeds its cash by 59.95M EUR. Its Piotroski F-score is 0 out of 9, a weak reading of its financial health.